Bioton S.A. | Cash Flow

Fiscal year is January-December. All values PLN Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
6,369.00
3,248.00
520,633.00
28,439.00
7,194.00
26,088
Depreciation, Depletion & Amortization
29,980.00
33,740.00
37,281.00
31,293.00
33,426.00
29,493
Other Funds
3,620.00
30.00
-
-
-
63,817
Funds from Operations
25,466.00
42,869.00
84,681.00
28,806.00
20,254.00
8,236
Changes in Working Capital
39,370.00
14,667.00
70,403.00
13,394.00
12,981.00
29,408
Net Operating Cash Flow
64,836.00
28,202.00
14,278.00
15,412.00
7,273.00
21,172
Capital Expenditures
61,539.00
27,838.00
28,556.00
24,416.00
33,667.00
Sale of Fixed Assets & Businesses
4,856.00
3,914.00
165.00
3,534.00
10,286.00
Purchase/Sale of Investments
1,903.00
18,106.00
-
-
-
Net Investing Cash Flow
57,851.00
5,926.00
41,629.00
2,511.00
24,928.00
Issuance/Reduction of Debt, Net
17,351.00
17,115.00
25,414.00
38,124.00
33,572.00
Net Financing Cash Flow
20,971.00
17,145.00
25,414.00
38,124.00
33,572.00
Net Change in Cash
13,986.00
5,131.00
1,937.00
56,047.00
49,900.00
Free Cash Flow
3,297.00
364.00
14,278.00
9,004.00
26,394.00
Other Sources
999.00
1,316.00
6,023.00
23,761.00
116.00
Exchange Rate Effect
-
-
-
-
1,327.00
Other Uses
264.00
1,424.00
19,261.00
368.00
1,663.00

About Bioton

View Profile
Address
Macierzysz, ul. Poznanska 12
Warsaw MZ 05
Poland
Employees -
Website http://www.bioton.pl
Updated 07/08/2019
BIOTON SA engages in the manufacture and production of medicines and pharmaceutical substances. The company offers oral hypoglycemic drug, foot cream and human insulin. It operates through the following segment: BIOTON S.